The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment

NCT05885399 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Pheochromocytoma, Metastatic
Pheochromocytoma Malignant
Paraganglioma, Malignant

Interventions

DRUG: Penpulimab

Sponsor

Peking Union Medical College Hospital